Douglas J Sharp, the Senior Managing Director of $IVZ, sold 160,000 shares of the company on 10-31-2025 for an estimated $3,768,832. We received data on the trade from a recent SEC filing. This was a sale of approximately 99.9% of their shares of this class of stock. Following this trade, they now own 192 shares of this class of $IVZ stock.
$IVZ Insider Trading Activity
$IVZ insiders have traded $IVZ stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $IVZ stock by insiders over the last 6 months:
- DOUGLAS J SHARP (Senior Managing Director) sold 160,000 shares for an estimated $3,768,832
- STEPHANIE BUTCHER (Senior Managing Director) sold 103,192 shares for an estimated $2,282,710
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IVZ Hedge Fund Activity
We have seen 292 institutional investors add shares of $IVZ stock to their portfolio, and 243 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TRIAN FUND MANAGEMENT, L.P. removed 8,544,987 shares (-36.9%) from their portfolio in Q2 2025, for an estimated $134,754,444
- ROYAL BANK OF CANADA added 7,952,857 shares (+814.3%) to their portfolio in Q2 2025, for an estimated $125,416,554
- GOLDMAN SACHS GROUP INC added 3,915,804 shares (+55.7%) to their portfolio in Q2 2025, for an estimated $61,752,229
- FIRST TRUST ADVISORS LP added 3,315,480 shares (+5065.4%) to their portfolio in Q2 2025, for an estimated $52,285,119
- BLACKROCK, INC. removed 2,660,005 shares (-5.6%) from their portfolio in Q2 2025, for an estimated $41,948,278
- VANGUARD GROUP INC added 2,162,629 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $34,104,659
- MARSHALL WACE, LLP removed 1,916,513 shares (-74.6%) from their portfolio in Q2 2025, for an estimated $30,223,410
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IVZ Price Targets
Multiple analysts have issued price targets for $IVZ recently. We have seen 11 analysts offer price targets for $IVZ in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Kenneth S. Lee from RBC Capital set a target price of $25.0 on 10/30/2025
- Benjamin Budish from Barclays set a target price of $25.0 on 10/29/2025
- Alexander Blostein from Goldman Sachs set a target price of $26.5 on 10/29/2025
- Glenn Schorr from Evercore ISI Group set a target price of $26.0 on 10/09/2025
- Michael Cyprys from Morgan Stanley set a target price of $26.0 on 10/06/2025
- Brennan Hawken from BMO Capital set a target price of $28.0 on 10/03/2025
- Michael Carrier from B of A Securities set a target price of $25.0 on 10/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
